Answer
Tetrabenazine reversibly binds to vesicular monoamine transporters, inhibiting monoamine re-uptake in central presynaptic nerve terminals and depleting dopamine, which reduces movement and chorea severity.
Sources for this answer
- Tetrabenazine 25 mg TabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked